Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for RANK ligand (compound)
Most Correlated Studies
- Osteoclast cultures of Nfatc1 conditional knockout mice
- Bone marrow monocytes treated with M-CSF and soluble RANKL
- Bone marrow-derived macrophage (BMM) cells treated with RANKL
- Vascular smooth muscle cells with OPG siRNA, RANKL or TRAIL treated
- Fetal thymus organ culture with JMJD6 knockout with or without RANKL stimulation
Most Relevant Literature
- An LGR4 agonist activates the GSK‑3β pathway to inhibit RANK‑RANKL signaling during osteoclastogenes…
- The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpo…
- RANK and RANKL Expression in Salivary Gland Tumors.
- OPG/RANK/RANKL Axis in Egyptian Children With Acute Lymphoblastic Leukemia After Maintenance Therapy…
- The Non-Bone-Related Role of RANK/RANKL Signaling in Cancer.
Most Relevant Clinical Trials
- Oral Care of Patients Treated With Anti-RANK-ligand Antibodies for a Giant Cell Tumour
- NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand …
- A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monothera…
- Osteoporosis in RETT Syndrome
- Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk
